Home > > > > Report Detail

Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)

Publisher Name :
Date: 27-Feb-2017
No. of pages: 220

Executive Summary

Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines.Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.   

Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions.While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO’s.

Global Anti- infective vaccine Market is forecasted to grow at a CAGR of 5.88% during 2016 – 2021F, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.

According to Azoth Analytics research report, "Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)", Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over ~5.88% during 2016 - 2021.

Scope of the Report

Segmentation by Vaccine Type


  • Anti- Bacterial

  • Anti- Viral


Segmentation by Sub - Type


  • Anti- Bacterial- Diseases Type, TB Typhoid and Other’s

  • Anti- Viral Type- Diseases Type, Hepatitis, Influenza and Other’s


Coverage by Region


  • North America

  • Europe

  • Asia Pacific

  • ROW


Coverage by Country


  • USA

  • Canada

  • UK

  • France

  • India

  • China


Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation
3.1. Escalate the focus on the Asia Pacific Region
3.2. Focus on R&D

4. Global Anti-infective Vaccines Market: Product Overview

5. Global Anti-infective Vaccines Market: Growth and Forecast
5.1 Global Anti-infective Vaccines Market
5.1.1. By Value (Historic 2011-15)
5.1.2. By Value ( Forecast 2016E-2021F)

6. Global  Anti-Bacterial Vaccines Market: Growth and Forecast
6.1 Global  Anti-Bacterial Vaccines Market
6.1.1. By Value(Historic 2011-15)
6.1.2 By Value( Forecast 2016E-2021F)

7. Global Anti-Viral Vaccines Market: Growth and Forecast
7.1 Global Anti-Viral Vaccines Market
7.1.1 By Value(Historic 2011-15)
7.1.2 By Value( Forecast 2016E-2021F)

8. Global Anti-infective Vaccines Market - By Disease
8.1 Global Typhoid Vaccines Market
8.1.1. By Value-Actual(2015)
8.1.2. By Value-Forecast(2021)
8.2 Global Tuberculosis Vaccines Market
8.2.1. By Value-Actual(2015)
8.2.2. By Value -Forecast(2021)
8.3 Global Other Anti-Bacterial Vaccines Market
8.3.1. By Value-Actual(2015)
8.3.2 By Value- Forecast (2021)
8.4 Global Influenza Vaccines Market
8.4.1. By Value-Actual(2015)
8.4.2 By Value- Forecast (2021)
8.5 Global Hepatitis Vaccines  Market
8.5.1 By Value-Actual(2015)
8.5.2 By Value- Forecast (2021)
8.6 Global Other Anti-Viral Vaccines Market
8.6.1 By Value-Actual(2015)
8.6.2 By Value- Forecast (2021)

9. Global Anti-Infective vaccines- Pipeline Analysis
9.1 Typhoid Vaccines
9.2 Tuberculosis Vaccines
9.3 Tetanus & Diptheria Vaccines
9.4 Other Anti-Bacterial Vaccines
9.5 Influenza Vaccines
9.6 Hepatitis Vaccines
9.7 Polio Vaccines
9.8 Other Anti-Viral Vaccines

10. North America Anti-infective Vaccines Market: Sizing and Growth
10.1 By Value-Actual(2015)
10.2 By Value- Forecast (2021)
10.3 North America Anti-Bacterial Vaccines Market
10.3.1 By Value-Actual(2015)
10.3.2 By Value- Forecast (2021)
10.4 North America Anti-Viral Vaccines Market
10.4.1 By Value-Actual(2015)
10.4.2 By Value Forecast ( 2016-2021)

11. North America Anti-Infective Vaccines Market- By Disease
11.1 North America Typhoid Vaccines Market
11.1.1 By Value-Actual(2015)
11.1.2 By Value- Forecast (2021)
11.2 North America Tuberculosis Vaccines Market
11.2.1 By Value-Actual(2015)
11.2.2 By Value- Forecast (2021)
11.3 North America Other Anti-Bacterial Vaccines Market
11.3.1 By Value-Actual(2015)
11.3.2 By Value- Forecast (2021)
11.4 North America Influenza Vaccines Market
11.4.1 By Value-Actual(2015)
11.4.2 By Value- Forecast (2021)
11.5 North America Hepatitis Vaccines Market
11.5.1 By Value – Actual ( 2011-2015)
11.5.2 By Value Forecast ( 2016-2021)
11.6 North America Other Anti-Viral Vaccines Market
11.6.1 By Value-Actual(2011-2015)
11.6.2 By Value- Forecast (2016-2021)
11.7 US Anti-Infective Vaccines Market
11.7.1 By Value-Actual(2011-2015)
11.7.2 By Value- Forecast (2016-2021)
11.8 US  Anti-Bacterial Vaccines Market
11.8.1 By Value-Actual(2011-2015)
11.8.2 By Value- Forecast (2016-2021)
11.9 US  Anti-Viral Vaccines Market
11.9.1 By Value-Actual(2015)
11.9.2 By Value- Forecast (2021)
11.10 Canada Anti-Infective Vaccines Market
11.10.1 By Value-Actual(2011-2015)
11.10.2 By Value- Forecast (2016-2021)
11.13 North America Others Market
11.13.1 By Value-Actual(2011-2015)
11.13.2 By Value- Forecast (2016-2021)

12. Europe Anti-Infective Vaccines Market: Sizing and Growth
12.1 By Value-Actual(2015)
12.2 By Value- Forecast (2021)
12.3 Europe Anti-Bacterial Vaccines Market
12.3.1 By Value-Actual(2015)
12.3.2 By Value- Forecast (2021)
12.4 Europe Anti-Viral Vaccines Market
12.4.1 By Value-Actual(2015)
12.4.2 By Value Forecast ( 2016-2021)

13. Europe Anti-Infective Vaccines Market- By Disease
13.1 Europe Typhoid Vaccines Market
13.1.1 By Value-Actual(2015)
13.1.2 By Value- Forecast (2021)
13.2 Europe Tuberculosis Vaccines Market
13.2.1 By Value-Actual(2015)
13.2.2 By Value- Forecast (2021)
13.3 Europe Other Anti-Bacterial Vaccines Market
13.3.1 By Value-Actual(2015)
13.3.2 By Value- Forecast (2021)
13.4 Europe Influenza Vaccines Market
13.4.1 By Value-Actual(2015)
13.4.2 By Value- Forecast (2021)
13.5 Europe Hepatitis Vaccines Market
13.5.1 By Value – Actual ( 2011-2015)
13.5.2 By Value Forecast ( 2016-2021)
13.6 Europe Other Anti-Viral Vaccines Market
13.6.1 By Value-Actual (2011-2015)
13.6.2 By Value- Forecast (2016-2021)
13.7 UK Anti-Infective Vaccines Market
13.7.1 By Value-Actual(2011-2015)
13.7.2 By Value- Forecast (2016-2021)
13.8 UK Anti-Bacterial Vaccines Market
13.8.1 By Value-Actual(2011-2015)
13.8.2 By Value- Forecast (2016-2021)
13.9 UK  Anti-Viral Vaccines Market
13.9.1 By Value-Actual(2015)
13.9.2 By Value- Forecast (2021)
13.10 France Anti-Infective Vaccines Market
13.10.1 By Value-Actual(2011-2015)
13.10.2 By Value- Forecast (2016-2021)
13.11 France Anti-Bacterial Vaccines Market
13.11.1 By Value-Actual(2011-2015)
13.11.2 By Value- Forecast (2016-2021)
13.12 France  Anti-Viral Vaccines Market
13.12.1 By Value-Actual (2015)
13.12.2 By Value- Forecast (2021)
13.13 Europe  Others Market
13.13.1 By Value-Actual(2011-2015)
13.13.2 By Value- Forecast (2016-2021)

14. APAC Anti-Infective Vaccines Market: Sizing and Growth
14.1 By Value-Actual(2015)
14.2 By Value- Forecast (2021)
14.3 APAC Anti-Bacterial Vaccines Market
14.3.1 By Value-Actual(2015)
14.3.2 By Value- Forecast (2021)
14.4 Europe Anti-Viral Vaccines Market
14.4.1 By Value-Actual(2015)
14.4.2 By Value Forecast ( 2016-2021)

15. APAC  Anti-Infective Vaccines Market- By Disease
15.1 APAC Typhoid Vaccines Market
15.1.1 By Value-Actual(2015)
15.1.2 By Value- Forecast (2021)
15.2 APAC Tuberculosis Vaccines Market
15.2.1 By Value-Actual(2015)
15.2.2 By Value- Forecast (2021)
15.3 APAC Other Anti-Bacterial Vaccines Market
15.3.1 By Value-Actual(2015)
15.3.2 By Value- Forecast (2021)
15.4 APAC Influenza Vaccines Market
15.4.1 By Value-Actual(2015)
15.4.2 By Value- Forecast (2021)
15.5 APAC Hepatitis Vaccines Market
15.5.1 By Value – Actual ( 2011-2015)
15.5.2 By Value Forecast ( 2016-2021)
15.6 APAC Other Anti-Viral Vaccines Market
15.6.1 By Value-Actual(2011-2015)
15.6.2 By Value- Forecast (2016-2021)
15.7 India Anti-Infective Vaccines Market
15.7.1 By Value-Actual(2011-2015)
15.7.2 By Value- Forecast (2016-2021)
15.8 India Anti-Bacterial Vaccines Market
15.8.1 By Value-Actual(2011-2015)
15.8.2 By Value- Forecast (2016-2021)
15.9 India Anti-Viral Vaccines Market
15.9.1 By Value-Actual(2015)
15.9.2 By Value- Forecast (2021)
15.10 China Anti-Infective Vaccines Market
15.10.1 By Value-Actual(2011-2015)
15.10.2 By Value- Forecast (2016-2021)
15.11 China Anti-Bacterial Vaccines Market
15.11.1 By Value-Actual(2011-2015)
15.11.2 By Value- Forecast (2016-2021)
15.12 China Anti-Viral Vaccines Market
15.12.1 By Value-Actual(2015)
15.12.2 By Value- Forecast (2021)
15.13 APAC  Others Market
15.13.1 By Value-Actual(2011-2015)
15.13.2 By Value- Forecast (2016-2021)

16. ROW  Anti-Infective Vaccines Market
16.1 By Value-Actual(2015)
16.2 By Value- Forecast (2021)

17. Market Dynamics
17.1. Drivers
17.2. Challenges
17.3. Trends

18. Policy and Regulatory Landscape

19. Competitive Landscape
19.1. Company Profiles
19.1.1 Teva Pharmaceutical Industries Ltd.
19.1.2 Emergent Biosolutions
19.1.3 Sanofi Pasteur, Inc.
19.1.4 GlaxoSmithKline
19.1.5 Merck & Co., Inc.
19.1.6 CSL Limited
19.1.7 Astrazeneca
19.1.8 Pfizer
19.1.9 Serum Institute Of India Pvt. Ltd.
19.1.10 Protein Sciences Corporation

List of Tables

Table 1:Typhoid Vaccines – Pipeline Products (Company and Stages)
Table 2:Tuberculosis Vaccines – Pipeline Products (Company and Stages)
Table 3:Tetanus and Diptheria Vaccines – Pipeline Products (Company and Stages)

List of Figures

Figure 1: Global Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Anti-infective Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 4: Global Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 5: Global Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 6: Global Anti-Viral Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 7: Global Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Typhoid Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 11: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 12: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 13: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 14: Global Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 15: Global Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 16: Global Hepatitis Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 17: Global Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 18: Global Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 19: North America Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 20: North America Anti-infective Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 21: North America Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 22: North America Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 23: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 24: North America Anti-Viral Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 25: North America Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 26: North America Typhoid Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 27: North America Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 28: North America Tuberculosis Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 29: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 30: North America Other Anti-Bacterial Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 31: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 32: North America Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 33: North America Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 34: North America Hepatitis Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 35: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 36: North America Other Anti-Viral Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 37: US Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 38: US Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 39: US Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 40: Canada Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 41: Canada Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 42: Canada Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Million)
Figure 43: North America Others Anti-Infective Vaccines  Market Size, By Value, 2011-2021 (USD Billion)
Figure 44: Europe Anti-Infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 45: Europe  Anti-infective Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 46: Europe Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 47: Europe Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 48: Europe Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 49: Europe Anti-Viral Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 50: Europe Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 51: Europe Typhoid Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 52: Europe Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 53: Europe Tuberculosis Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 54: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 55: Europe Other Anti-Bacterial Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 56: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 57: Europe Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 58: Europe Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 59: Europe Hepatitis Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 60: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 61: Europe Other Anti-Viral Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 62: UK Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 63: UK Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 64: UK Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 65: France Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 66: France Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 67: France Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 68: Europe Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 69: APAC Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 70: APAC Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 71: APAC Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 72: APAC Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 73: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 74: APAC Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 75: APAC Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 76: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 77: APAC Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 78: APAC Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 79: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 80: APAC Other Anti-Bacterial Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 81: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 82: APAC Influenza Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 83: APAC Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 84: APAC Hepatitis Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 85: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 86: APAC Other Anti-Viral Vaccines  Market Size, By Value, 2016E-2021F (USD Billion)
Figure 87: India Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 88: India Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 89: India Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 90: China Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 91: China Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 92: China Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 93: APAC other’s Anti-Infective Vaccines  Market Size, By Value, 2011-2021 (USD Billion)
Figure 94: ROW Market Size, By Value, 2011-2015 (USD Million)
Figure 95: ROW Market Size, By Value, 2016E-2021F (USD Million)

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs